Hospital Del Mar — Clinical Trial Site

480 Registered trials

196 Currently recruiting

Organisation

Hospital Del Mar

Location

Barcelona, Spain

Identifier

ORG-100028631

Address

Passeig Maritim De La Barceloneta 25-29, 08003, Spain

Departments

-
#034016 Oncología Médica
#2245; Nefrología
#2309:servicio de neurología
#2351: Servicio de dermatología
#2900; Cardiología
#3411 - Reumatología
#3456: Cardiología
#3850: Hematología
#6004:Oncología
#7004: Oncología Médica
#766; Oncología
#9102: Hematología Clínica
1101: Dermatología
1306: Hematologia y Transfusion
1307: Alliance Member
1400:Dermatología
2752; Dermatología
2802: Reumatología
34005: Oncología Médica
3411: Reumatología
3456: Servicio Dermatología
40890: Dermatologia
6500: Dermatología
7002:reumatología
7003: Oncología Médica
724007: Oncología Médica
9249: Servicio Dermatología
9751; Dermatología
Anaesthesiology
Anaesthesiology and Resucitation
Anestesiología y Reanimación
Anesthesiology
Anesthesiology, Resuscitation and Pain Therapy Department
Cap de Secció d´Hepatologia, Servei de Digestiu
Cardiologia
Cardiology
cirugia
Clinic Hematology
Clinical Hematology
Critical Care Unit
Departamento de Neurología
Department of Infectious Diseases
Department of Urology
Dermathology unit
Dermatología
Dermatology
Dermatology department
Digestive service
Digestología
Endrocrinology
Farmacología Clínica
Gastroenterologia
Gastroenterology
Gastroenterology Unit
General and Digestive System Surgery
General Surgery
Ginecology and Obstetrics
Gynecological Department
Haematology
Heart Failure Unit
Hematología
Hematología Clínica
hematology
Hematology and Hemotherapy
Hematology department
Hepatology Section, Department of Gastroenterology
Hospital de día de infecciosas
Hospital del Mar
Hospital del Mar_Cardiología - Ensayos Clínicos
Hospital Pharmacy
IMIM-Hospital del Mar
Infecciosas
Infectious Disease Unit
Infectious Diseases
Infectious Diseases Department
Infectious Diseases Service
Integrative Pharmacology and Systems Neuroscience research group
Integrative Pharmacology and Systems Neurosciences
Intensive Care Unit
Medical Oncology
Medical Oncology Department
Medicina Interna /Enfermedades Infecciosas
Medicine
N/A
NA
Nefrología
Nefrología y Trasplante Renal
Nefrology
Nephrology
Nephrology and Kidney Transplant
Nephrology and Trasplant
Nephrology Department
Nephrology department, Pg. Marítim de la Barcelona, 25-29, Ciutat Vella, 08003 Barcelona, Spain
Nephrology Service
Neumología
Neumology
Neuro-Oncology
Neurology
Neurology department
Neurology Service
Nuclear Medicine
Obstetricia y Ginecología
Oftalmologia
Oncolgy
Oncologia
Oncología médica
ONCOLOGU
Oncology
Oncology department
Oncology Service
Otorhinolaryngolog Service
Otorhinolaryngology
Otorrinolaringología
Parc de Salut Mar - Hospital del Mar
Pharmacology
Pneumology
Pneumology service
Psiquiatría
Psychiatry
Pulmonology
Research Institute
Reumatología
Rheumatology
Servei de Dermatologia
Servei h'Hematologia Clinica
Servicio de digestivo
Servicio de Angiología y Cirugía vascular
Servicio de Cardiologia
Servicio de Dermatologia
Servicio de Digestología
Servicio de Enfermedades Infecciosas
Servicio de Hematología
Servicio de Hematologia Clinica
Servicio de Infecciosas
Servicio de Nefrologia
Servicio de Neumología
Servicio de Neurología
Servicio de Oncologia
Servicio de Oncología médica
Servicio de Otorrinolaringología
Servicio de Reumatologia
Servicio de Urologia
Servico de Reumatologia
Thoracic Oncology
Treatment Resistant Schizophrenia and Psychosocial Rehabilitation Unit
Tuberculosis Unit, Service of Infectious Diseases
UCG Enfermedades Infecciosas, Microbiología y Medicina preventiva
Unidad de Cancer Genitourinaria
Unidad de Gestión Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva.
Unidad de Insuficiencia Cardiaca
Unidad del Dolor
Unitat de deteriorament cognitiu i transtorns del moviment
URC
Urologia
Urology
Urology-Oncology
Vascular Surgery

Clinical trials at this site (480)

Search interface

A Phase 2/3 study to evaluate safety and efficacy of the combination of Bel- CHOP/ Fol-COP drugs against CHOP in newly diagnosed Peripheral … Recruiting

2023-507803-76-00 Peripheral T-Cell Lymphoma 10 2024-09-26
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy Recruiting

2023-508811-21-00 Refractory Focal Onset Epilepsy 10 2024-09-25
A follow-up study to test long-term treatment with BI 1015550 in people with pulmonary fibrosis who took part in a previous study with BI 10… Recruiting

2023-507353-15-00 idiopathic pulmonary fibrosis (IPF) 5 2024-09-10
Study evaluating whether giving 177Lu-PSMA-617 to men having a spreading prostate cancer which does not respond well to the current standard… Recruiting

2022-502408-57-00 Novo metastatic hormone-sensitive prostate cancer (mHSP 5 2024-09-04
A multicenter, phase 2 randomized, open label study to evaluate the efficacy and security of zanubrutinib in combination with obinutuzumab i… Recruiting

2023-504647-14-00 Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic 4 2024-09-02
A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Lisaftoclax (APG-2575) in Previously Treated Patients with Chro… Recruiting

2023-508005-24-00 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 5 2024-08-01
A study to investigate efficacy, safety, and tolerability of mavorixafor in participants with congenital and acquired primary autoimmune and… Recruiting

2023-508482-32-00 Neutropenias 5 2024-07-22
Talazoparib plus Enzalutamide after progression to prior ARPi in Metastatic Prostate Cancer Recruiting

2023-510536-37-00 Prostate Cancer 4 2024-07-05
Registry-based randomized trial to determine the role of Oxygen in acute Pulmonary Embolism Recruiting

2024-511959-18-01 Acute Pulmonary Embolism 5 2024-07-01
Efficacy of perioperative duloxetine in patients at high risk for developing chronic postsurgical pain after inguinal hernia repair: a multi… Recruiting

2023-505860-12-00 Chronic postsurgical pain after inguinal hernia repair 5 2024-06-26
Phase 2, randomised study of Radspherin® in patients with primary advanced epithelial cancer with peritoneal metastasis that are homologous … Recruiting

2023-508497-28-00 Carcinomatosis of peritoneal cavity 4 2024-06-05
Phase 3 extension study to evaluate long-term safety of two regimens of ianalumab in participants with systemic lupus erythematosus (SIRIUS-… Recruiting

2023-505929-14-00 Systemic Lupus Erythematosus 5 2024-05-21
Bevacizumab plus encorafenib-cetuximab in BRAF-V600E mutated metastatic colorectal cancer, a phase II study with a safety lead-in cohort, th… Recruiting

2023-509204-15-00 Metastatic colorectal cancer 4 2024-05-17
Bomedemstat vs Best Available Therapy (BAT) for Essential Thrombocythemia Recruiting

2023-504865-21-00 Essential Thrombocythemia patients who have an inadequa 5 2024-04-15
Efficacy and safety of different antimicrobial DURATions for the treatment of Infections associated with Osteosynthesis Material implanted a… Recruiting

2023-508442-18-00 Patients with an infection of the osteosynthesis materi 5 2024-04-14
RADAR: A randomised phase III trial with a PET response adapted design comparing ABVD +/- ISRT with A2VD +/- ISRT in patients with previousl… Recruiting

2022-500031-37-00 stage IA/IIA Hodgkin lymphoma 5 2024-04-08
A Global Pivotal Placebo-Controlled Study of LY3537982 in Combination with Pembrolizumab and LY3537982 in Combination with Pembrolizumab, Pe… Recruiting

2023-503412-33-00 Stage IIIB-IIIC or Stage IV KRAS G12C-mutant non-small 5 2024-03-29
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) Recruiting

2023-504031-41-00 ER+/HER2- Early Breast Cancer 5 2024-03-25
A Randomized, Multicenter, Placebo-controlled, Phase 3 study to Evaluate the Efficacy and Safety of HER2/neu Peptide GLSI-100 (GP2 + GM-CSF)… Recruiting

2023-504323-25-01 breast cancer 5 2024-03-19
A Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety and Tolerabilit… Recruiting

2023-504835-42-00 Heart Failure (Heart Failure with Reduced Ejection Frac 4 2024-02-29
RECOVERY Recruiting

2023-507441-29-00 Pneumonia 5 2024-02-29
A Long-Term Extension Study to Learn More About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adul… Recruiting

2023-504863-17-00 1. Lupus Erythematosus, Cutaneous, Subacute 2. Chronic 5 2024-02-21
Trial to Better Characterize the Status of HRD leading to a Benefit from Olaparib in Combination with Bevacizumab in Patients with Advanced … Recruiting

2024-517363-24-00 Advanced FIGO Stage III‐IV High Grade Serous or Endomet 4 2024-02-16
A multi-centre, open, prospective, randomized, parallel-group, 24-month study to compare the outcome of receiving continued immunosuppressio… Recruiting

2023-506879-98-00 Renal transplantation 6 2024-01-22